title: Krypton laser for proliferative diabetic retinopathy: the Krypton Argon Regression of Neovascularization Study.
abstract: The Krypton Argon Regression of Neovascularization Study (KARNS) is a multicenter, randomized, controlled clinical trial designed to determine the efficacy of red krypton laser photocoagulation in the treatment of proliferative diabetic retinopathy.
authors: Retina Associates of Cleveland, Retinal Laboratory, Ohio 44122.
authors: L J
authors: LJ
authors: Singerman
authors: F L
authors: FL
authors: Ferris
authors: R P
authors: RP
authors: Mowery
authors: A J
authors: AJ
authors: Brucker
authors: R P
authors: RP
authors: Murphy
authors: B C
authors: BC
authors: Lerner
authors: G J
authors: GJ
authors: Mincey
mesh_terms: D002986:Clinical Trials as Topic; D003930:Diabetic Retinopathy / Q000175:diagnosis / Q000601:surgery*; D005451:Fluorescein Angiography; D005500:Follow-Up Studies; D006801:Humans; D007834:Lasers; D008028:Light Coagulation; D009389:Neovascularization, Pathologic; D011897:Random Allocation; D012160:Retina / Q000098:blood supply